New Clinical Trial – Natreon’s PrimaVie® Shilajit Ingredient Showed Results of Improved Skin Health in Adult Women

FOR IMMEDIATE RELEASE

Natreon Inc.
2-D Janine Place
New Brunswick, NJ 08901
732-296-1080

 

NEW BRUNSWICK, NJ, July 3, 2019 – Natreon announces the results of the recently published randomized, double-blind, placebo controlled clinical study from Ohio State University Wexner Medical Center for PrimaVie®, its patented shilajit extract. PrimaVie® is an organic humic substance containing urolithins, fulvic acid, and micro minerals. Natreon is committed to continued scientific investment and research focused on the Beauty-FromWithin and skin health categories. This marks the 10th clinical trial published by Natreon for its innovative biome optimized shilajit extract. Continue reading…

Full Press Release

 

Contact:
Dr. Sanni Raju, CEO & Chairman or Bruce Brown, President
2-D Janine Place
New Brunswick, NJ 08901
Tel: 732-296-1080
E-mail: info@natreoninc.com

Recent Posts